Church & Dwight is the leading global producer of baking soda... Show more
Church & Dwight Co., Inc. maintains a robust position in the consumer staples sector, leveraging a diversified portfolio spanning household products, personal care, and specialty divisions. With approximately 77% of sales domestic and power brands—such as Arm & Hammer, Trojan, and TheraBreath—accounting for 75% of revenue and profits, the company benefits from strong pricing power and brand loyalty. Its "evergreen strategy" targets 4% organic sales growth through 2030 via innovation cycles, targeted acquisitions, and portfolio optimization, including recent exits from underperforming lines to sharpen focus.
Competitively, CHD faces giants like Procter & Gamble but differentiates through niche leadership in categories like oral care and natural products. Medium-term tailwinds include international expansion (18% of sales) and digital marketing enhancements, though structural risks from private-label competition and shifting preferences toward premium eco-friendly options require vigilant execution.
The Q1 2026 earnings release on May 1, 2026, stands as the immediate focal point, with consensus expecting EPS of $0.93 and revenue around $1.46 billion. This report could validate early progress on 2026 guidance and highlight momentum in high-growth brands like TOUCHLAND. Positive surprises in volume metrics or margin updates may spur analyst upgrades.
Longer-term, strategic partnerships and product launches in personal care, alongside capital allocation via share repurchases or bolt-on M&A (mergers and acquisitions), could drive sentiment. Recent analyst actions show mixed revisions—JPMorgan and RBC trimming targets slightly to $98-$112—yet the overall consensus remains moderately optimistic with 10 buys versus fewer sells.
In the consumer staples arena, CHD's trajectory ties closely to consumer demand cycles and inflation trends. As a defensive play, staples exhibit resilience amid economic uncertainty, but persistent high interest rates could curb discretionary spending spillover into essentials. Cooling inflation supports volume recovery after pricing-led growth, enhancing real consumption.
Commodity input costs, particularly for detergents and packaging, remain a sensitivity, though hedging and supply chain efficiencies mitigate volatility. Geopolitical tensions may pressure international growth, while regulatory pushes for sustainable packaging align with CHD's innovation pipeline. Broader tech adoption in e-commerce bolsters direct-to-consumer channels.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it includes searchable prediction categories, historical context, and alert-oriented functionality for timely insights. Explore the Trend Prediction Engine to enhance your market analysis.
Looking to 2026 and beyond, Church & Dwight's outlook hinges on delivering 3%-4% organic growth and 5%-8% EPS expansion, fueled by volume gains across divisions and gross margin improvements. Long-term themes include market expansion in emerging international regions, cost structure evolution through automation, and margin sustainability via premiumization. Technology transitions like AI-driven consumer insights and sustainable formulations address competitive threats from agile rivals.
Regulatory developments around product safety and ESG (environmental, social, and governance) standards will shape compliance costs, while capital allocation prioritizes dividends, buybacks, and growth investments. Consensus analyst expectations embed modest upside, with price targets averaging $103 amid a balanced rating distribution, underscoring steady but not explosive growth potential.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a manufacturer of sodium bicarbonate and sodium bicarbonate based products
Industry HouseholdPersonalCare
A.I.dvisor indicates that over the last year, CHD has been closely correlated with CL. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHD jumps, then CL could also see price increases.
The Moving Average Convergence Divergence (MACD) for CHD turned positive on June 09, 2026. Looking at past instances where CHD's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 12, 2026. You may want to consider a long position or call options on CHD as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CHD moved above its 50-day moving average on June 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHD crossed bullishly above the 50-day moving average on May 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHD advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .
CHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.522) is normal, around the industry mean (27.150). P/E Ratio (32.092) is within average values for comparable stocks, (56.431). Projected Growth (PEG Ratio) (3.045) is also within normal values, averaging (2.836). CHD has a moderately low Dividend Yield (0.012) as compared to the industry average of (0.035). P/S Ratio (3.802) is also within normal values, averaging (2.404).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.